Presentations: FDA's Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds Public Hearing
Part 15 Public Hearing
May 31, 2019
Below is a list of participants with affiliation who gave formal presentations with slide decks at the FDA’s Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds Part 15 Public Hearing. The presenters are categorized by topic and are listed in alphabetical order by last name.
Persons with disabilities having problems accessing the PDF files below may email stakeholderengagement@fda.hhs.gov for assistance.
State/Government Officials/Entities
- Erin Bubb - Pennsylvania Department of Agriculture
Association of American Feed Control Officials
Academia
- Barry Gidal, University of Wisconsin-Madison
Drug Interactions with Cannabidiol (CBD): Cause for Concern? - Igor Grant, Center for Medicinal Cannabis Research, University of California, San Diego
- Bill Gurley, University of Arkansas for Medical Sciences, College of Pharmacy
Content vs. Label Claim: A Survey of CBD Content in Commercially Available Products - Rick Kingston, University of Minnesota
Is There a Path forward for FDA to Allow Consumer CBD Products? Challenges and Opportunity - Igor Koturbash, Center for Dietary Supplements Research, University of Arkansas
Safety Concerns Associated with Cannabidiol-Rich Cannabis Extract - Michelle Peace, Virginia Commonwealth University
CBD Products and Electronic Cigarettes: The Tangle of Two Industries and Public Demand - Ryan Vandrey, Johns Hopkins University
Recent Research Findings and the Legalization of Hemp - Larry Walker, University of Mississippi, National Center for Natural Products Research
- Elise Weerts, Johns Hopkins University, School of Medicine
Scientific Research on Cannabis Abuse and its Potential Therapeutic Use
Agriculture (non-government)
Consumers
- Jaclyn Bowen, International Association for Cannabis Testing
- David Evans, Cannabis Industry Victims Educating Litigators
The Victims of the Marijuana Industry Need Enforcement of Federal Law - Lisa Gill, Consumer Reports
- Yael Ossowski, Consumer Choice Center
Smart Regulation of Products Containing Cannabis or Cannabis-Derived Compounds, Specifically Cannabidiol (CBD)
Health Professionals
- Ann Allworth, Education Solutions
The Endocannabinoid System as Scientific Proof that Cannabis is Medicine - Jerry Bryant, Vyripharm Biopharmaceuticals
Vyripharm Testimony before the Food and Drug Administration - Najla Guthrie, KGK Science
Inclusion of Hemp-derived CBD Extracts as Food Additives and Dietary Ingredients - Lucille Vega, Vega Direct Medical Family Practice
CBD: A Physician’s Testimony - Sue Sisley, Scottsdale Research Institute
Barriers to CBD/Cannabis Clinical Trials in US
Manufacturers
- Justin Blehar, Genco Pura Oil Company, LLC
- Richard Brumfield, Full Spectrum Omega, Inc.
- Guy Chamberland, Tetra BioPharma Inc
- Josh Epstein, Socati
Launching a Race to the Top - Bill Grubb, Noramco
Noramco Cannabidiol FDA Presentation - Deb Kimless, Pure Green
CBD Integrated Data Presentation, Clinical Safety & Efficacy, Manufacturing & Labeling - Douglas MacKay, CV Sciences
Hemp Ingredients, Dietary Supplements, Conventional Food - Ray Mannion, Zynerba Pharmaceuticals, Inc.
Cannabinoid Manufacturing: Product Quality & Safety - Rosemary Mazanet, Columbia Care Inc.
- Marwan Moheyeldien, Maryland Packaging
Quality Regulations in CBD Products - Alice Mead, Greenwich Biosciences
Achieving the Full Potential of Cannabis-Derived Medicines - Stephen Mueller, Mile High Labs
- Aaron Secrist, NOW Health Group, Inc.
Cannabis Regulatory Process - James Sharkey, Therabis, LLC
Summary of Cannabidiol Safety Studies - Priyanka Sharma, Kazmira LLC
- Thuy Vu, Hammer Enterprises
Extraction, Manufacturing, and Product Quality of Cannabis and Cannabis-Derived Products in Colorado
Other
- Aubree Adams, Moms Strong
It’s Changed my Home. Pueblo Colorado: The Napa Valley of Marijuana - Susan Audino, S.A. Audino & Associates, LLC
- James Beck, Parkinson's Foundation
Medical Cannabis & Parkinson’s Disease - Scott Coates, AOAC Research Institute, AOAC INTERNATIONAL
Cannabis Analytical Science Program - Daniel Fabricant, Natural Products Association
- Jacqueline French, Epilepsy Foundation
Epilepsy Foundation: CBD for Epilepsy - Jeffrey Gitto, Vanguard Legal PLLC
Potential Legal Pathways for the Sale of Non- psychotropic Cannabinoids - Garrett Graff, Hoban Law Group
Products Containing Cannabis or Cannabis-Derived Compounds - Youn Lee, RTI International
Consumer Behavior and Assessing Effects of Cannabis Products - Brian Malkin, Arent Fox LLP
- Steve Mister, Council for Responsible Nutrition
- Robert Morgan, American Society for Testing and Materials (ASTM) International
D37 Cannabis, ASTM Background & Overview - Sheri Orlowitz, Artemis Holdings /Marijuana Policy Project (MPP)
MPP: We Change Lives. Helping End Cannabis Prohibition and its Harmful Effects - Matt Sica - ANSI National Accreditation Board
Conformity Assessments for Hemp Testing Laboratories - David Steinberg, Steinberg & Associates, Inc.
Cannabidiol (CBD): The Coming Crisis
Patients
Public Safety
- Heather Despres, Americans for Safe Access
- John Redman, Community Alliances for Drug Free Youth
- Denise Valenti, Impairment Measurement Marijuana and Driving (IMMAD), LLC
Is there a Risk of Blindness with CBD?
Retailers/Distributors
- Shawn Hauser, Vicente Sederberg LLC
Cannabis Trade Federation - Dana Mcmurchy, Harvard CBD Health Center, Oklahomans for Health
Oklahoma Activist - Valentina Milanova, Daye
Hemp Tampons, CBD-Infused, Plastic-Free